Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 2, 2009, Pages 342-346

  Seguin, Philippe ^a   Fédun, Yannick ^a   Laviolle, Bruno ^b   Nesseler, Nicolas ^a   Donnio, Pierre Yves ^b   Mallédant, Yannick ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Antimicrobial therapy; Empirical therapy; In vitro susceptibility; Surgery

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; VANCOMYCIN;

ADULT; AEROBIC BACTERIUM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE SEVERITY; DISK DIFFUSION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INTENSIVE CARE; LAPAROTOMY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; POSTOPERATIVE INFECTION; REOPERATION; RISK FACTOR; TREATMENT DURATION;

EID: 77950207293     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp439     Document Type: Article

References (21)

1. Montravers P, Gauzit R, Muller C et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996; 23: 486-94.
2. Roehrborn A, Thomas L, Potreck O et al. The microbiology of postoperative peritonitis. Clin Infect Dis 2001; 33: 1513-9.
3. Dupont H, Carbon C, Carlet J. Monotherapy with a broad-spectrum b-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother 2000; 44: 2028-33.
4. Seguin P, Laviolle B, Chanavaz C et al. Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy. Clin Microbiol Infect 2006; 12: 980-5.
5. Solomkin JS, Mazuski JE, Baron EJ et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003; 37: 997-1005.
6. Mazuski JE, Sawyer RG, Nathens AB et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt) 2002; 3: 175-233.
7. de Man P, Verhoeven BA, Verbrugh HA et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355: 973-8.
8. Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA 1993; 270: 1965-70.
9. Trouillet JL, Chastre J, Vuagnat A et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157: 531-9.
10. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101: 1481-3.
11. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
12. Bellomo R, Kellum J, Ronco C. Acute renal failure: time for consensus. Intensive Care Med 2001; 27: 1685-8.
13. Barie PS, Vogel SB, Dellinger EP et al. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group. Arch Surg 1997; 132: 1294-302.
14. Christou NV, Turgeon P, Wassef R et al. Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group. Arch Surg 1996; 131: 1193–201.
15. Bertrand X, Mouchot L, Jebabli M et al. Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum b-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study. Eur J Clin Microbiol Infect Dis 2008; 27: 1113-7.
16. Moalla M, Baratin D, Giard M et al. Incidence of methicillin-resistant Staphylococcus aureus nosocomial infections in intensive care units in Lyon university hospitals, France, 2003-2006. Infect Control Hosp Epidemiol 2008; 29: 454-6.
17. Wendt C, Lin D, von Baum H. Risk factors for colonization with third-generation cephalosporin-resistant Enterobacteriaceae. Infection 2005; 33: 327-32.
18. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
19. Lynch JP III, Zhanel GG. Streptococcus pneumoniae: does antimicrobial resistance matter? Semin Respir Crit Care Med 2009; 30:210-38.
20. Shorr AF. Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med 2009; 37: 1463-9.
21. Mulier S, Penninckx F, Verwaest C et al. Factors affecting mortality in generalized postoperative peritonitis: multivariate analysis in 96 patients. World J Surg 2003; 27: 379-84.